Kendrick Lee1, Steven R Laviolette2, Daniel B Hardy3,4. 1. Department of Physiology and Pharmacology, Western University, London, ON, Canada. 2. Department of Anatomy and Cell Biology, Western University, London, ON, Canada. 3. Department of Physiology and Pharmacology, Western University, London, ON, Canada. daniel.hardy@schulich.uwo.ca. 4. Departments of Obstetrics and Gynecology, Children's Health Research Institute, Lawson, Health Research Institute, Western University, London, ON, Canada. daniel.hardy@schulich.uwo.ca.
Abstract
BACKGROUND: Cannabis use in pregnancy leads to fetal growth restriction (FGR), but the long-term effects on cardiac function in the offspring are unknown, despite the fact that fetal growth deficits are associated with an increased risk of developing postnatal cardiovascular disease. We hypothesize that maternal exposure to Δ9-tetrahydrocannabinol (Δ9-THC) during pregnancy will impair fetal development, leading to cardiac dysfunction in the offspring. METHODS: Pregnant Wistar rats were randomly selected and administered 3 mg/kg of Δ9-THC or saline as a vehicle daily via intraperitoneal injection from gestational days 6 to 22, followed by echocardiogram analysis of cardiac function on offspring at postnatal days 1 and 21. Heart tissue was harvested from the offspring at 3 weeks for molecular analysis of cardiac remodelling. RESULTS: Exposure to Δ9-THC during pregnancy led to FGR with a significant decrease in heart-to-body weight ratios at birth. By 3 weeks, pups exhibited catch-up growth associated with significantly greater left ventricle anterior wall thickness with a decrease in cardiac output. Moreover, these Δ9-THC-exposed offsprings exhibited increased expression of collagen I and III, decreased matrix metallopeptidase-2 expression, and increased inactivation of glycogen synthase kinase-3β, all associated with cardiac remodelling. CONCLUSIONS: Collectively, these data suggest that Δ9-THC-exposed FGR offspring undergo postnatal catch-up growth concomitant with cardiac remodelling and impaired cardiac function early in life. IMPACT: To date, the long-term effects of perinatal Δ9-THC (the main psychoactive component) exposure on the cardiac function in the offspring remain unknown. We demonstrated, for the first time, that exposure to Δ9-THC alone during rat pregnancy results in significantly smaller hearts relative to body weight. These Δ9-THC-exposed offsprings exhibited postnatal catch-up growth concomitant with cardiac remodelling and impaired cardiac function. Given the increased popularity of cannabis use in pregnancy along with rising Δ9-THC concentrations, this study, for the first time, identifies the risk of perinatal Δ9-THC exposure on early postnatal cardiovascular health.
BACKGROUND: Cannabis use in pregnancy leads to fetal growth restriction (FGR), but the long-term effects on cardiac function in the offspring are unknown, despite the fact that fetal growth deficits are associated with an increased risk of developing postnatal cardiovascular disease. We hypothesize that maternal exposure to Δ9-tetrahydrocannabinol (Δ9-THC) during pregnancy will impair fetal development, leading to cardiac dysfunction in the offspring. METHODS: Pregnant Wistar rats were randomly selected and administered 3 mg/kg of Δ9-THC or saline as a vehicle daily via intraperitoneal injection from gestational days 6 to 22, followed by echocardiogram analysis of cardiac function on offspring at postnatal days 1 and 21. Heart tissue was harvested from the offspring at 3 weeks for molecular analysis of cardiac remodelling. RESULTS: Exposure to Δ9-THC during pregnancy led to FGR with a significant decrease in heart-to-body weight ratios at birth. By 3 weeks, pups exhibited catch-up growth associated with significantly greater left ventricle anterior wall thickness with a decrease in cardiac output. Moreover, these Δ9-THC-exposed offsprings exhibited increased expression of collagen I and III, decreased matrix metallopeptidase-2 expression, and increased inactivation of glycogen synthase kinase-3β, all associated with cardiac remodelling. CONCLUSIONS: Collectively, these data suggest that Δ9-THC-exposed FGR offspring undergo postnatal catch-up growth concomitant with cardiac remodelling and impaired cardiac function early in life. IMPACT: To date, the long-term effects of perinatal Δ9-THC (the main psychoactive component) exposure on the cardiac function in the offspring remain unknown. We demonstrated, for the first time, that exposure to Δ9-THC alone during rat pregnancy results in significantly smaller hearts relative to body weight. These Δ9-THC-exposed offsprings exhibited postnatal catch-up growth concomitant with cardiac remodelling and impaired cardiac function. Given the increased popularity of cannabis use in pregnancy along with rising Δ9-THC concentrations, this study, for the first time, identifies the risk of perinatal Δ9-THC exposure on early postnatal cardiovascular health.
Authors: Emily E Campbell; Jason Gilliland; Paula D N Dworatzek; Barbra De Vrijer; Debbie Penava; Jamie A Seabrook Journal: J Biosoc Sci Date: 2017-03-08
Authors: Shayna N Conner; Victoria Bedell; Kim Lipsey; George A Macones; Alison G Cahill; Methodius G Tuuli Journal: Obstet Gynecol Date: 2016-10 Impact factor: 7.661
Authors: Marian Jarlenski; Jonathan W Koma; Jennifer Zank; Lisa M Bodnar; Debra L Bogen; Judy C Chang Journal: Am J Obstet Gynecol Date: 2017-08-24 Impact factor: 8.661
Authors: Louisa Degenhardt; Alize J Ferrari; Bianca Calabria; Wayne D Hall; Rosana E Norman; John McGrath; Abraham D Flaxman; Rebecca E Engell; Greg D Freedman; Harvey A Whiteford; Theo Vos Journal: PLoS One Date: 2013-10-24 Impact factor: 3.240
Authors: Rose Schrott; Jennifer L Modliszewski; Andrew B Hawkey; Carole Grenier; Zade Holloway; Janequia Evans; Erica Pippen; David L Corcoran; Edward D Levin; Susan K Murphy Journal: Epigenetics Chromatin Date: 2022-09-10 Impact factor: 5.465
Authors: Mohammed H Sarikahya; Samantha Cousineau; Marta De Felice; Kendrick Lee; Karen Kw Wong; Marieka V DeVuono; Tony Jung; Mar Rodríguez-Ruiz; Tsun Hay Jason Ng; Dana Gummerson; Emma Proud; Daniel B Hardy; Ken K-C Yeung; Walter Rushlow; Steven R Laviolette Journal: eNeuro Date: 2022-10-10